An Gao Wu

Title: Overview of Inventor An Gao Wu

Introduction

An Gao Wu is an esteemed inventor based in Taipa, Macau. He has made significant contributions in the field of neurodegenerative disease treatment, exemplified by his innovative research and patent.

Latest Patents

An Gao Wu holds a patent for "Triterpenoid obtainable from Hedera helix for treatment of neurodegenerative diseases." This innovative method outlines the administration of at least one triterpenoid derived from the Hedera helix plant to treat patients suffering from neurodegenerative diseases such as Parkinson's disease and Huntington's disease. The patent includes detailed methodologies for extracting the triterpenoid and a process for inducing autophagy in cells, which results in notable reductions of mutant huntingtin and A53T α-synuclein protein levels. This research highlights the triterpenoid's ability to inhibit the oligomerization of α-synuclein and the formation of huntingtin inclusions via the AMPK-mTOR dependent autophagy-inducing pathway.

Career Highlights

Currently, An Gao Wu is affiliated with the Macau University of Science and Technology. His role at the university allows him to delve deeper into research aimed at addressing critical health issues associated with neurodegeneration. His work not only showcases his inventive capabilities but also his commitment to advancing medical science.

Collaborations

Throughout his career, An Gao Wu has collaborated with notable peers, including Yuen Kwan Law and Kam Wai Wong. These collaborations have been instrumental in enhancing the depth and scope of research undertaken at the university.

Conclusion

An Gao Wu's pioneering work in the field of neurodegenerative disease treatment, particularly through the patenting of his unique method, marks him as a significant figure in medical innovation. His contributions are expected to pave the way for future advancements in the treatment of debilitating conditions, ultimately improving the quality of life for those affected.